Northern Trust’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.26M Buy
1,478,851
+71,152
+5% +$280K ﹤0.01% 2544
2025
Q4
$5.73M Buy
1,407,699
+89,203
+7% +$399K ﹤0.01% 2391
2025
Q3
$4.68M Buy
1,318,496
+164,182
+14% +$594K ﹤0.01% 2539
2025
Q2
$3.15M Sell
1,154,314
-145,009
-11% -$299K ﹤0.01% 2744
2025
Q1
$2.18M Buy
1,299,323
+110,977
+9% +$310K ﹤0.01% 2881
2024
Q4
$1.94M Buy
1,188,346
+60,004
+5% +$179K ﹤0.01% 3045
2024
Q3
$4.69M Buy
1,128,342
+273,770
+32% +$1.44M ﹤0.01% 2509
2024
Q2
$4.67M Sell
854,572
-11,569
-1% -$92.2K ﹤0.01% 2442
2024
Q1
$8.66M Sell
866,141
-20,832
-2% -$156K ﹤0.01% 2129
2023
Q4
$3.62M Buy
886,973
+54,366
+7% +$200K ﹤0.01% 2684
2023
Q3
$3.22M Buy
832,607
+16,908
+2% +$90.9K ﹤0.01% 2680
2023
Q2
$4.86M Buy
815,699
+53,299
+7% +$307K ﹤0.01% 2519
2023
Q1
$2.49M Sell
762,400
-18,246
-2% -$72.9K ﹤0.01% 2845
2022
Q4
$3.08M Sell
780,646
-9,869
-1% -$48.3K ﹤0.01% 2764
2022
Q3
$4.74M Sell
790,515
-3,160
-0.4% -$22.8K ﹤0.01% 2522
2022
Q2
$5.1M Buy
793,675
+35,379
+5% +$225K ﹤0.01% 2496
2022
Q1
$6.26M Sell
758,296
-35,891
-5% -$290K ﹤0.01% 2450
2021
Q4
$12.3M Buy
794,187
+8,069
+1% +$156K ﹤0.01% 2092
2021
Q3
$17.7M Buy
786,118
+494,789
+170% +$10.4M ﹤0.01% 1886
2021
Q2
$5.73M Buy
291,329
+127,148
+77% +$2.88M ﹤0.01% 2760
2021
Q1
$5.5M Buy
+164,181
New +$5.35M ﹤0.01% 2688

Other funds holding SANA